We are monitoring the impact of COVID-19 & Recession alarm on North America Regenerative Medicine Market Get in touch with us for detailed analysis Know More
Share on

North America Regenerative Medicine Market Research Report – Segmented By Product, Therapy, Application & Country (the United States, Canada and Rest of North America) – Industry Analysis on Size, Share, COVID-19 Impact, Trends & Growth Forecast (2022 to 2027)

Published: January, 2022
ID: 241
Pages: 145

North America Regenerative Medicine Market Size (2022 to 2027)

The size of the North America regenerative medicine market is forecasted to be growing at a CAGR of 20.5% from 2022 to 2027 and worth USD 16.47 billion by 2027 from USD 6.48 billion in 2022.

A few of the key drivers that are boosting the growth of the North America regenerative medicine market are rising incidence of bone and joint diseases, growing awareness among the population, the emergence of advanced technologies in tissue engineering and stem cell therapy, rise in demand for regenerative medicines in the treatment of chronic diseases, cancer, and orthopedic disorders, enhancements in nanotechnology, and rise in adoption of CAR-T cell therapies

The North America Regenerative medicine market is further expected to expand at a high pace owing to significant growth opportunities such as increased efforts of researchers to develop regenerative medicines due to unavailability of organs for transplantation, increasing investments in R & D for developing innovative products, significant competitors and research institutes of the market are likely to release a wide range of products in gene therapy and stem cells during the forecast period, potential risks like organ damage or failed functionality that are involved in transplanting organs traditionally, is leading to rising in acceptance of regenerative medicine for transplanting organs.

The factors that diminish the growth of the North America regenerative medicine market are side effects associated with implantation, stringent rules for using human tissues, treatment is costly, growing adoption of cell-based products like stem cells, regulations, and policies on regenerative medicines.

This research report on the North American regenerative medicine market has been segmented and sub-segmented into the following categories:

By Product:

  • Cell-Based Products                            
    • Autologous Cell-Based Products
    • Allogeneic Cell-Based Products  
  • Acellular Products           

By Therapy: 

  • Cell Therapy
  • Gene Therapy
  • Tissue Engineering
  • Immunotherapy

By Application: 

  • Orthopedic & Musculoskeletal Spine                           
  • Dermatology                          
  • Cardiovascular                       
  • Central Nervous System                   
  • Oncology                 
  • Diabetes                  
  • Other Applications

By Country: 

  • The U.S.
  • Canada
  • Rest of North America

Based on the region, the North America regenerative medicine market is predicted to dominate the global market by contributing the largest share of revenue owing to market catalyzing factors such as growing awareness of personalized medicine and emergence of CAR-T cell therapies, increase in investments for developing innovative regenerative drugs, the United States contributes significant share among all of the North American countries owing to the presence of notable market players and research institutes that are developing innovative techniques and availability of high-end technology. In contrast, the Canadian regenerative medicine market is estimated to grow at a higher CAGR during the forecast period.

KEY MARKET PLAYERS:

A few of the promising companies operating in the North American Regenerative Medicines Market profiled in this report are Vertex Pharmaceuticals Incorporated, Acelity L.P. Inc., Celgene Corporation, StemCells, Inc., Organogenesis Inc., NuVasive, Inc., Vericel Corporation (Genzyme), Japan Tissue Engineering Co., Ltd.,  Cytori Therapeutics Inc., Advantagene, Inc. and Mesoblast Ltd.

1. Introduction                                                                                 

                1.1 Market Definition                                                                    

                1.2 Study Deliverables                                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                                          

                1.4 General Study Assumptions                                                                

2. Research Methodology                                                                                           

                2.1 Introduction                                                                               

                2.2 Research Phases                                                                      

                                2.2.1 Secondary Research                                                           

                                2.2.2 Primary Research                                                 

                                2.2.3 Econometric Modelling                                                      

                                2.2.4 Expert Validation                                                  

                2.3 Analysis Design                                                                         

                2.4 Study Timeline                                                                          

3. Overview                                                                                       

                3.1 Executive Summary                                                                

                3.2 Key Inferences                                                                         

                3.3 New Developments                                                                               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                                                    

                4.1 Market Drivers                                                                          

                4.2 Market Restraints                                                                    

                4.3 Key Challenges                                                                         

                4.4 Current Opportunities in the Market                                                                              

5. Market Segmentation                                                                                              

                5.1 Introduction                                                                               

                5.2 Product                                                                        

                                5.2.1 Introduction                                                           

                                5.2.2 Cell-Based Products                                                            

                                                5.2.2.1 Autologous Cell-Based Products                                

                                                5.2.2.2 Allogeneic Cell-Based Products                                  

                                5.2.3 Acellular Products                                                

                5.3 Therapy                                                                       

                                5.3.1 Introduction                                                           

                                5.3.2 Cell Therapy                                                           

                                5.3.3 Gene Therapy                                                       

                                5.3.4 Tissue Engineering                                                               

                                5.3.5 Immunotherapy                                                   

                5.4 Application                                                                 

                                5.4.1 Introduction                                                           

                                5.4.2 Orthopedic & Musculoskeletal Spine                                                           

                                5.4.3 Dermatology                                                          

                                5.4.4 Cardiovascular                                                       

                                5.4.5 Central Nervous System                                                   

                                5.4.6 Oncology                                                 

                                5.4.7 Diabetes                                                  

                                5.4.8 Other Applications                                                               

6. Geographical Analysis                                                                                              

                                6.1 Introduction                                                               

                                6.2 United States                                                            

                                6.3 Canada                                                         

7. Strategic Analysis                                                                                       

                7.1 PESTLE analysis                                                                         

                                7.1.1 Political                                                     

                                7.1.2 Economic                                                 

                                7.1.3 Social                                                         

                                7.1.4 Technological                                                         

                                7.1.5 Legal                                                          

                                7.1.6 Environmental                                                       

                7.2 Porter’s Five analysis                                                                              

                                7.2.1 Bargaining Power of Suppliers                                                        

                                7.2.2 Bargaining Power of Consumers                                                    

                                7.2.3 Threat of New Entrants                                                     

                                7.2.4 Threat of Substitute Products and Services                                                              

                                7.2.5 Competitive Rivalry within the Industry                                                     

8. Market Leaders' Analysis                                                                                        

                8.1 Vertex Pharmaceuticals Incorporated (U.S.)                                                                

                                8.1.1 Overview                                                 

                                8.1.2 Product Analysis                                                   

                                8.1.3 Strategic Evaluation and Operations                                                            

                                8.1.4 Financial analysis                                                  

                                8.1.5 Legal issues                                                             

                                8.1.6 Recent Developments                                                       

                                8.1.7 SWOT analysis                                                       

                                8.1.8 Analyst View                                                          

                8.2 Acelity L.P. Inc. (U.S.)                                                                             

                8.3 Celgene Corporation (U.S.)                                                                 

                8.4 StemCells, Inc. (U.S.)                                                                              

                8.5 Organogenesis Inc.  (U.S.)                                                                    

                8.6 NuVasive, Inc. (U.S.)                                                                              

                8.7 Vericel Corporation (Genzyme) (U.S.)                                                                            

                8.8 Cytori Therapeutics Inc. (U.S.)                                                                            

                8.9 Advantagene, Inc. (U.S.)                                                                      

                8.10 Mesoblast Ltd. (Australia)                                                                  

9. Competitive Landscape                                                                                           

                9.1 Market share analysis                                                                            

                9.2 Merger and Acquisition Analysis                                                                       

                9.3 Agreements, collaborations and Joint Ventures                                                                         

                9.4 New Product Launches                                                                         

10. Expert Opinions                                                                                        

                10.1 Market Outlook                                                                     

                10.2 Investment Opportunities                                                                 

Appendix                                                                                           

                a) List of Tables                                                                

                b) List of Figures                                                                              

  1. North America Regenerative Medicine Market, By Region, From 2022 - 2027 (USD Million)
  2. North America Regenerative Medicine Market, By Product, From 2022 - 2027 (USD Million)
  3. North America Cell-Based Products Regenerative Medicine Market, By Region, From 2022 - 2027 (USD Million)
  4. North America Acellular Products Regenerative Medicine Market, By Region, From 2022 - 2027 (USD Million)
  5. North America Regenerative Medicine Market, By Therapy, From 2022 - 2027 (USD Million)
  6. North America Cell Therapy Regenerative Medicine Market, By Region, From 2022 - 2027 (USD Million)
  7. North America Gene Therapy Regenerative Medicine Market, By Region, From 2022 - 2027 (USD Million)
  8. North America Tissue Engineering Regenerative Medicine Market, By Region, From 2022 - 2027 (USD Million)
  9. North America Immunotherapy Regenerative Medicine Market, By Region, From 2022 - 2027 (USD Million)
  10. North America Regenerative Medicine Market, By Application, From 2022 - 2027 (USD Million)
  11. North America Orthopedic & Musculoskeletal Spine Regenerative Medicine Market, By Region, From 2022 - 2027 (USD Million)
  12. North America Dermatology Regenerative Medicine Market, By Region, From 2022 - 2027 (USD Million)
  13. North America Cardiovascular Regenerative Medicine Market, By Region, From 2022 - 2027 (USD Million)
  14. North America Central Nervous System Regenerative Medicine Market, By Region, From 2022 - 2027 (USD Million)
  15. North America Oncology Regenerative Medicine Market, By Region, From 2022 - 2027 (USD Million)
  16. North America Diabetes Regenerative Medicine Market, By Region, From 2022 - 2027 (USD Million)
  17. North America Other Applications of Regenerative Medicine Market, By Region, From 2022 - 2027 (USD Million)
  18. United States Regenerative Medicine Market, By Product, From 2022 - 2027 (USD Million)
  19. United States Regenerative Medicine Market, By Therapy, From 2022 - 2027 (USD Million)
  20. United States Regenerative Medicine Market, By Application, From 2022 - 2027 (USD Million)
  21. Canada Regenerative Medicine Market, By Product, From 2022 - 2027 (USD Million)
  22. Canada Regenerative Medicine Market, By Therapy, From 2022 - 2027 (USD Million)
  23. Canada Regenerative Medicine Market, By Application, From 2022 - 2027 (USD Million)
  24. North America Cell-Based Products Regenerative Medicine Market, By Type, From 2022 - 2027 (USD Million)
  25. North America Autologous Cell-Based Products Regenerative Medicine Market, By Region, From 2022 - 2027 (USD Million)
  26. North America Allogeneic Cell-Based Products Regenerative Medicine Market, By Region, From 2022 - 2027 (USD Million)
  27. United States Cell-Based Products Regenerative Medicine Market, By Type, From 2022 - 2027 (USD Million)
  28. Canada Cell-Based Products Regenerative Medicine Market, By Type, From 2022 - 2027 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

3335


pdf excel
$

3680


pdf excel powerbi
$

5520


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 3335

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample